Develops small molecule drugs targeting RNA-modifying proteins to treat cancers with high unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Accent Therapeutics leverages expertise in RNA-modifying protein (RMP) biology to develop small molecule therapeutics that target critical intracellular dependencies across multiple cancer types. The company’s approach aims to create first-in-class and best-in-class therapies for large patient populations with significant unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Accent Therapeutics Management Team
Investors
Atlas Venture Advisors Inc
Column Group
EcoR1 Capital
Accent Therapeutics Valuations & Financials
View real-time NPM data on Accent Therapeutics stock including daily Accent Therapeutics stock price estimates, valuation history, and historical share price information. Access Accent Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Accent Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Accent Therapeutics? Get in touch to learn more.
Similar Companies
like Accent Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
OncoPrecision
Healthcare & Life Sciences
Develops screening technology to predict cancer patients' therapy responses quickly, improving treatment outcomes.
ArkeaBio
Climate & Sustainability
Develops innovative vaccines to reduce methane emissions from ruminants, supporting sustainable and efficient global agriculture.
DebtBook
FinTech
Cloud-based treasury and accounting software platform helps government and nonprofit organizations manage debt, cash, and financial compliance.
Nana
Provides online training, resources, and job placement support for individuals pursuing careers in appliance repair.
Qwick
Commerce & Marketplaces
Digital staffing platform connecting hospitality professionals with businesses for flexible shift work and event staffing needs.
Tabby
Lets consumers split purchases or defer payment without interest, offering merchants increased sales and customers financial flexibility.
Lightning Labs
Web3 & Digital Assets
Creates power electronics which optimize energy conversion for electric vehicles and renewable systems.
Ottometric
Provides AI-powered software to automate and streamline ADAS validation and training for faster, safer, and more cost-effective vehicle development.
FAQ
We have answers
Accent Therapeutics stock does not trade on public stock exchanges. Accent Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Accent Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Accent Therapeutics Stock does not trade on public stock exchanges. In order to sell Accent Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Accent Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Accent Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Accent Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Accent Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Accent Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Accent Therapeutics is a private company and has not had an IPO. There is currently no Accent Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Accent Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
